PPT-The revision of Germany’s federal legal framework for opioid substitution treatment

Dr med Kenan MaricHorstmeyer Bonn Pharmacologist Addiction Medicine Department Narcotics Law Traffic in Narcotics int Narcotic Drug Affairs 2 European Conference on Addictive Behaviours and Dependences. A CVAHEC Summer Project. Simone Cotes, UVM MSW Student. Adrienne Jarvis, UVM Medical Student. Americans make up 4.6% of world population, yet consume 80% of global opioid supply . (Manchikanti & Singh, 2008). John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. IN ARMS September 26, 2016. Prepared by. Leslie . Hulvershorn. , MD. Medical Director,. . Division of Mental Health and . Addiction, FSSA. Leslie.Hulvershorn@fssa.IN.gov. Presented by. Dennis Ailes, MA. T Koshy. Setting the Context. CRVS . Registration & Certification of Vital Events. Measuring Characteristics and Trends. Identity Management . Establishing Identity. Authentication for Service Delivery. Medication Assisted Treatment For Opioid Use Disorders Shannon Allen, MD Jade Wellness Center July 19, 2018 Rates of Relapse in Opioid Use Disorders are High Benefits of Medication Assisted Treatments Medication Assisted Treatment (MAT) & Overdose Prevention. Michael Baca-Atlas, MD. Addiction Medicine . Fellow. UNC . School of . Medicine. June 14, 2019. Disclosures. The presenter has nothing to . . Dr M Suresh Kumar. Outline of presentation. Model of integrated OST and HIV care: evidence. Current status of OST in Asia: the response in the region. Gaps in response: Opportunity for improvement. William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP. V. P. & Chief Clinical Officer, Livengrin Foundation, Inc.. Ass’t. Clinical Professor, Doctoral Nursing Dept., . Drexel University. wlorman@livengrin.org. [name of speaker]. [title of speaker]. [. date]. Disclaimer. The contents of this presentation have not been formally disseminated by the Centers for Disease Control and Prevention, ChangeLab Solutions, and the Center for Public Health Practice. The contents should not be construed to represent any agency/organization determination or policy. . A. gonist Treatment . f. or . R. acial and Ethnic Minorities. Jawad M. Husain, MD . 1,2. , Devin Cromartie MD, MPH . 3,4. , Emma . Fitzelle. -Jones, MPH . 5. , . Annelise . Brochier. , MPH . 6. ,. . For Providers and Primary Care Teams. Medication Treatment for Opioid . U. se . D. isorder. Developer: . Joe Merrill, MD, University of . Washington,. Charles Morgan MD, and Anne . Griepp. MD, Western New York Collaborative. Farinaz . Khan, . Paul . Romo, MD. Disclosure. None. Outline. Opioids and the Neuroendocrine system. Misuse and Addiction. Treatment . Special Populations- forensics. Objective. By the end of this didactic, you will be able to:. Community Justice & Safety Symposium. March 3, 2020. Mae Katt, Nurse Practitioner. Outline. Topic: Opioid Addiction. Mae Katt, NP. Dr Claudette Chase. Edna . Quequish. Swanson . Kenequanash. . Questions & Discussion. Knox County . CON Application No. CN2401-002. Cedar Recovery of Middle Tennessee, LLC. Local company founded in 2015 and headquartered in Mt. Juliet.. Owns and operates 13 outpatient addiction treatment clinics in Tennessee and Virginia (“OBOTs” for Office Based Opioid Treatment), including 2 in Knoxville..